Latest Breaking News On - Extended release injectable suspension - Page 1 : comparemela.com

Alkermes plc: Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences

Alkermes plc: Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSandy coombsMarisa borgasanoLas vegasAripiprazole lauroxilCraig hopkinsonLaboratory tests for opioid detectionAlkermes incAmerican psychiatric associationInternational society for pharmacoeconomicsPsych congress elevateOutcomes researchAlkermes pharma irelandAmerican society of clinical psychopharmacologyHealthcare resource utilization research offer insights

New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024

New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEric hughesSanjeev sharmaEden kleinYael ashmanPharmacokinetic popKelley doughertyTeva neuroscience incNational pregnancy registry for atypical antipsychoticsInternational survey study to assess the perceptionsDrug administrationSchizophrenia international research societyTeva pharmaceutical industriesTeva pharmaceuticalsMental health services administrationTeva pharmaceutical industries ltd

Teva Pharmaceutical Industries Limited: New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY (risperidone) Extended-Release Injectable Suspension at SIRS 2024

Teva Pharmaceutical Industries Limited: New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY (risperidone) Extended-Release Injectable Suspension at SIRS 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDennis riedlEric hughesYael ashmanEden kleinKelley doughertyPharmacokinetic popSanjeev sharmaNational pregnancy registry for atypical antipsychoticsPopulation pharmacokinetic modeling following administration of olanzapineMental health services administrationDrug administrationInternational survey study to assess the perceptionsTeva pharmaceutical industries ltdSchizophrenia international research societyTeva pharmaceuticals

New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024

PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable formulation of risperidone microspheres Additional UZEDY.

United statesPharmacokinetic popEric hughesDrug administrationTeva pharmaceuticalsPopulation pharmacokinetic modeling following administration of olanzapineMental health services administrationTeva neuroscience incInternational survey study to assess the perceptionsNational pregnancy registry for atypical antipsychoticsTeva pharmaceutical industries ltdInternational survey assessing the perceptionsSchizophrenia international research societyTeva pharmaceutical industriesExecutive vice presidentChief medical officer

Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual.

United statesMarisa borgasanoSandy coombsAripiprazole lauroxilCraig hopkinsonResearch development at alkermesAlkermes pharma irelandUs national healthWellness survey dataPsych congressMental healthAlkermes incPoster presentations highlight companyBroad research commitmentSerious mental illnessAnnual psych congress